DekaBank Deutsche Girozentrale Sells 10,633 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

DekaBank Deutsche Girozentrale decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 925,789 shares of the healthcare conglomerate's stock after selling 10,633 shares during the quarter. UnitedHealth Group makes up approximately 0.9% of DekaBank Deutsche Girozentrale's portfolio, making the stock its 18th largest position. DekaBank Deutsche Girozentrale owned about 0.10% of UnitedHealth Group worth $474,990,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in UnitedHealth Group during the fourth quarter valued at about $26,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $28,000. Aster Capital Management DIFC Ltd bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $30,000. Kapitalo Investimentos Ltda bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $41,000. Finally, Copia Wealth Management bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $42,000. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Up 1.4%

Shares of UNH stock traded up $4.30 during mid-day trading on Friday, reaching $303.81. 9,789,082 shares of the company's stock traded hands, compared to its average volume of 7,687,343. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The company has a market cap of $275.60 billion, a P/E ratio of 12.72, a P/E/G ratio of 1.43 and a beta of 0.45. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The company's 50-day moving average price is $314.52 and its 200-day moving average price is $440.88.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter last year, the firm posted $6.91 EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.91%. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's dividend payout ratio is 37.02%.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on UNH. Erste Group Bank cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Truist Financial restated a "buy" rating and issued a $360.00 price objective (down from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Mizuho lowered their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a report on Friday, May 16th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a report on Wednesday, May 14th. Finally, KeyCorp decreased their target price on shares of UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a research note on Monday, June 2nd. One analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $415.00.

Insider Activity at UnitedHealth Group

In related news, CFO John F. Rex purchased 17,175 shares of the company's stock in a transaction dated Friday, May 16th. The shares were purchased at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the acquisition, the chief financial officer directly owned 203,796 shares in the company, valued at $59,329,091.52. The trade was a 9.20% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer directly owned 10,398 shares in the company, valued at approximately $3,171,390. The trade was a 5.36% decrease in their position. The disclosure for this sale can be found here. Insiders bought a total of 109,408 shares of company stock worth $31,607,768 in the last ninety days. 0.28% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.